PURR.AI

Purr AI is a biotechnology company leveraging generative artificial intelligence to revolutionize the discovery of small molecule therapeutics targeting G protein-coupled receptors (GPCRs). By integrating advanced machine learning models with high-throughput biological data, the company's platform identifies novel binding sites and optimizes lead compounds with high precision. Purr AI focuses on addressing undruggable or challenging GPCR targets across various therapeutic areas, including metabolic diseases and oncology. The company aims to significantly reduce the time and cost associated with early-stage drug discovery while increasing the success rate of clinical candidates.